Literature DB >> 80012

Study of antibodies against human melanoma produced by somatic cell hybrids.

H Koprowski, Z Steplewski, D Herlyn, M Herlyn.   

Abstract

We fused spleen lymphocytes obtained from mice immunized against a human melanoma cell line and melanoma-mouse hybrid cells with the P3 X 63 Ag8 mouse myeloma in order to produce hybrids secreting antibodies against a human melanoma. Antibodies secreted by individual hybrids were tested for their reaction with a panel of human melanoma, colorectal carcinoma, and normal cells in an indirect radioimmunoassay, and they displayed different specificities and crossreactivities. Some reacted only with melanomas, whereas others crossreacted with normal human or human colorectal carcinoma cells. By analysis of competitive binding of mixtures of monoclonal antibodies, it was possible to delineate different epitopes on melanomas. Hybrids growing in nude mice and producing antimelanoma antibody suppressed growth of melanoma tumors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 80012      PMCID: PMC392785          DOI: 10.1073/pnas.75.7.3405

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS.

Authors:  J W LITTLEFIELD
Journal:  Science       Date:  1964-08-14       Impact factor: 47.728

3.  Repertoire of antiviral antibodies expressed by somatic cell hybrids.

Authors:  W Gerhard; C M Croce; D Lopes; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

4.  The complete amino acid sequence of a mouse kappa light chain.

Authors:  J Svasti; C Milstein
Journal:  Biochem J       Date:  1972-06       Impact factor: 3.857

5.  A microtest radioimmunoassay for noncytotoxic tumor-specific antibody to cell-surface antigens.

Authors:  L T Goldstein; N R Klinman; L A Manson
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

6.  Physical properties of human interferon prepared in vitro and in vivo.

Authors:  T C Merigan; D F Gregory; J K Petralli
Journal:  Virology       Date:  1966-08       Impact factor: 3.616

7.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

8.  Genetic analysis with man-mouse somatic cell hybrids. Linkage between human lactate dehydrogenase B and peptidase B genes.

Authors:  A S Santachiara; M Nabholz; V Miggiano; A J Darlington; W Bodmer
Journal:  Nature       Date:  1970-07-18       Impact factor: 49.962

9.  Alteration of cell surfaces with increased tumorigenicity.

Authors:  Z Steplewski; W Kilarski; A Grabska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1977       Impact factor: 4.291

10.  Production of antibodies against influenza virus by somatic cell hybrids between mouse myeloma and primed spleen cells.

Authors:  H Koprowski; W Gerhard; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

View more
  68 in total

Review 1.  Monoclonal antibodies. Hybrid myelomas--a revolution in serology and immunogenetics.

Authors:  R G Kennett
Journal:  Am J Hum Genet       Date:  1979-09       Impact factor: 11.025

2.  Radioimmunoassay of glioma-associated antigen in cerebrospinal fluid and its usefulness for the diagnosis and monitoring of human glioma.

Authors:  J Yoshida; R Yamamoto; T Wakabayashi; M Nagata; H Seo
Journal:  J Neurooncol       Date:  1990-02       Impact factor: 4.130

3.  Remembrances of Hilary Koprowski from a Surgeon's Perspective.

Authors:  Henry F Sears
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-06

4.  Factors influencing antibody-mediated cytotoxicity during the immunotherapy of Rauscher-virus-induced myeloid leukemic cells.

Authors:  D Berends; T H van der Kwast; N J de Both; P G Mulder
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Utilization of monoclonal antibodies to evaluate the involvement of Campylobacter jejuni in proliferative ileitis in Syrian hamsters (Mesocricetis auratus).

Authors:  H F Stills; R R Hook; R F Sprouse
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

6.  Monoclonal antibodies reactive with human myeloid leukaemia cells.

Authors:  E D Ball; M W Fanger
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

7.  Monoclonal antibody against ependymoma-derived cell line.

Authors:  Y Mihara; Y Matsukado; S Goto; Y Ushio; S Tokumitsu; K Takahashi
Journal:  J Neurooncol       Date:  1992-01       Impact factor: 4.130

8.  Serial studies of autologous antibody reactivity to squamous cell carcinoma of the head and neck.

Authors:  D R Vlock; B Arnold; J Humpierres; D R Schwartz; S R Baker; C J Krause; N Swanson; T E Carey
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

9.  Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines.

Authors:  R F Irie; L L Sze; R E Saxton
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

Review 10.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.